Eldagsen, Germany

Werner Stuhmer


Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 103(Granted Patents)


Location History:

  • Springe, DE (1977)
  • Eldsagsen, DE (1980)
  • Eldagsen, DE (1976 - 1986)

Company Filing History:


Years Active: 1976-1986

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Werner Stuhmer: Innovator in Benzodiazepine Derivatives

Introduction

Werner Stuhmer is a notable inventor based in Eldagsen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of benzodiazepine derivatives. With a total of 11 patents to his name, Stuhmer's work has had a considerable impact on pharmaceutical chemistry.

Latest Patents

Stuhmer's latest patents include a process for making benzodiazepine derivatives. This involves converting benzodiazocines to benzodiazepines through specific thermal treatments or reactions with Lewis acids. His innovative methods allow for the production of benzodiazepines that are otherwise substituted in the 2-position, enhancing their pharmaceutical applications. Another significant patent involves the synthesis of 1,4-benzodiazepins, which are created by heating acyldiamines in the presence of phosphorus oxychloride, followed by reactions with alkali metal alkoxides.

Career Highlights

Throughout his career, Stuhmer has worked with prominent companies such as Kali-Chemie Aktiengesellschaft and Kali-Chemie Pharma GmbH. His expertise in chemical processes has been instrumental in advancing the production of various pharmaceutical compounds.

Collaborations

Stuhmer has collaborated with notable colleagues, including Wolfgang Milkowski and Horst Zeugner. These partnerships have contributed to the successful development of his innovative chemical processes.

Conclusion

Werner Stuhmer's contributions to the field of benzodiazepine derivatives exemplify his innovative spirit and dedication to advancing pharmaceutical chemistry. His patents and collaborations reflect a commitment to improving chemical processes and enhancing drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…